Founded in 2014, Innovipharm, classified under reg no. 08886792 is an active company. Currently registered at 2 Woodlands Lane CH48 8DA, Wirral the company has been in the business for ten years. Its financial year was closed on 31st March and its latest financial statement was filed on 2023-03-31. Since 2019-09-05 Innovipharm Ltd is no longer carrying the name Pharmnovo Uk.
There is a single director in the company at the moment - David K., appointed on 26 January 2015. In addition, a secretary was appointed - Jeanette K., appointed on 26 January 2015. Currenlty, the company lists one former director, whose name is Bengt V. and who left the the company on 1 October 2020. In addition, there is one former secretary - David K. who worked with the the company until 26 January 2015.
| Office Address | 2 Woodlands Lane |
| Office Address2 | West Kirby |
| Town | Wirral |
| Post code | CH48 8DA |
| Country of origin | United Kingdom |
| Registration Number | 08886792 |
| Date of Incorporation | Tue, 11th Feb 2014 |
| Industry | Other research and experimental development on natural sciences and engineering |
| End of financial Year | 31st March |
| Company age | 10 years old |
| Account next due date | Tue, 31st Dec 2024 (239 days left) |
| Account last made up date | Fri, 31st Mar 2023 |
| Next confirmation statement due date | Sun, 25th Feb 2024 (2024-02-25) |
| Last confirmation statement dated | Sat, 11th Feb 2023 |
Position: Secretary
Appointed: 26 January 2015
Position: Director
Appointed: 26 January 2015
The register of PSCs who own or control the company consists of 2 names. As BizStats established, there is David K. This PSC has 25-50% voting rights and has 25-50% shares. The second one in the persons with significant control register is Bengt V. This PSC owns 25-50% shares and has 25-50% voting rights.
David K.
| Notified on | 6 April 2016 |
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
Bengt V.
| Notified on | 6 April 2016 |
| Ceased on | 1 December 2020 |
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
| Pharmnovo Uk | September 5, 2019 |
| Profit & Loss | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Accounts Information Date | 2015-02-28 | 2016-02-29 | 2017-02-28 | 2018-02-28 | 2019-02-28 | 2020-02-29 | 2021-02-28 | 2022-03-31 | 2023-03-31 |
| Net Worth | 100 | 100 | |||||||
| Balance Sheet | |||||||||
| Current Assets | 100 | 7 990 | 2 235 | 564 | 1 870 | 1 021 | 1 184 | 151 | 150 |
| Net Assets Liabilities | 100 | -3 343 | -31 286 | -11 025 | -13 328 | -771 | 51 | 150 | |
| Debtors | 100 | ||||||||
| Net Assets Liabilities Including Pension Asset Liability | 100 | 100 | |||||||
| Reserves/Capital | |||||||||
| Called Up Share Capital | 100 | 100 | |||||||
| Shareholder Funds | 100 | 100 | |||||||
| Other | |||||||||
| Accrued Liabilities Not Expressed Within Creditors Subtotal | 7 890 | ||||||||
| Average Number Employees During Period | 1 | 1 | |||||||
| Creditors | 5 578 | 31 850 | 12 895 | 14 349 | 1 955 | 100 | |||
| Net Current Assets Liabilities | 100 | 7 990 | -3 343 | -31 286 | -11 025 | -13 328 | -771 | 51 | 150 |
| Other Operating Expenses Format2 | 7 377 | 2 112 | |||||||
| Profit Loss | -2 527 | ||||||||
| Staff Costs Employee Benefits Expense | 10 668 | 11 370 | |||||||
| Total Assets Less Current Liabilities | 100 | 7 990 | -3 343 | -31 286 | -11 025 | -13 328 | -771 | 51 | 150 |
| Turnover Revenue | 18 045 | 10 955 | |||||||
| Accruals Deferred Income | 7 890 | ||||||||
| Number Shares Allotted | 100 | ||||||||
| Other Operating Charges Format2 | 7 377 | ||||||||
| Par Value Share | 1 | ||||||||
| Share Capital Allotted Called Up Paid | 100 | ||||||||
| Staff Costs | 10 668 | ||||||||
| Turnover Gross Operating Revenue | 18 045 | ||||||||
| Type | Category | Free download | |
|---|---|---|---|
| CS01 |
Confirmation statement with no updates 2024-02-11 filed on: 22nd, February 2024 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy